University of Dundee

Latest News

November 2020

  • In4Derm team
    30 Nov 2020

    The o2h human health EIS Fund has announced its intention to lead an investment into In4Derm, an innovative drug discovery company that is developing next generation topical and oral therapies for widespread inflammatory conditions such as eczema and rheumatoid arthritis. Syndicating with o2h ventures are Meltwind and Wren to complete a first investment in In4Derm. A spin out from the School, the team has been recognised as Scotland’s top spin out opportunity for 2020 having won the top prize in the 2019 Converge Challenge competition.  

  • Manu De Rycker
    30 Nov 2020

    Dr Manu De Rycker has become an Independent Investigator and has been awarded a New Investigator Research Grant of over £700k from the Medical Research Council (MRC) to study Trypanosoma cruzi parasite heterogeneity and persister parasites.

  • Barley
    26 Nov 2020

    An international research team including scientists from the James Hutton Institute and the University of Dundee has reached a milestone on the way to unravelling the species-wide genetic diversity of domesticated barley.

  • University of Dundee logo on the Tower Building
    18 Nov 2020

    The University of Dundee has been named the best seat of learning in Scotland for supporting spinout businesses, according to new rankings.

  • 18 Nov 2020

    Six University of Dundee researchers have been named on a “who’s who” list of the world’s most influential academics. Four experts from the University’s School of Life Sciences, and a further two from the School of Medicine, have been named in Clarivate’s Highly Cited Researchers 2020 list.

  • Dundee Discoveries Past and Present
    16 Nov 2020

    Locals are invited to explore Dundee’s innovation and discovery in medicine and biology in a new series of self-guided walking tours produced by the University of Dundee.   Dundee is celebrated internationally for its pioneering work in medical sciences, in particular the University of Dundee’s ground-breaking research into cancer, diabetes, drug development and surgical techniques, but the city has a great deal of extraordinary stories in medicine and biology still unknown to many. 

  • Professor Victoria Cowling
    06 Nov 2020

    Three spinout projects from the University of Dundee with the potential to deliver significant healthcare benefits have received more than £250,000 from Scottish Enterprise to support their development. Softech received funding via Scottish Enterprise’s in-year High Growth Spin-out Programme (HGSP) while RNACapRx and Data Driven Health Solutions received support as part of an additional funding package for innovative early stage businesses whose routes to investment and growth have been impacted by the Covid-19 pandemic.

  • From left: Nicola Darling and Kris Clark
    03 Nov 2020

    Research by Kris Clark, a former postdoc in Philip Cohen lab, led to the discovery eight years ago that the SIK subfamily of protein kinases suppress the production of the anti-inflammatory cytokine IL-10 by phosphorylating and activating CRTC3, co-activator of the transcription factor CREB.  Excitingly, pharmacological inhibition of the SIKs greatly enhanced the production of IL-10, and transformed macrophages from an inflammatory M1 state to an anti-inflammatory M2b state that is thought to be important for the resolution of inflammation and the repair of tissue damage.